59 related articles for article (PubMed ID: 31703968)
1. Diagnostic Accuracy of Contrast-Enhanced Ultrasonography in Papillary Thyroid Microcarcinoma Stratified by Size.
Huang K; Bai Z; Bian D; Yang P; Li X; Liu Y
Ultrasound Med Biol; 2020 Feb; 46(2):269-274. PubMed ID: 31703968
[TBL] [Abstract][Full Text] [Related]
2. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study.
Xu Y; Qi X; Zhao X; Ren W; Ding W
Medicine (Baltimore); 2019 Jan; 98(4):e14051. PubMed ID: 30681562
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Nomogram Based on Multimodality Ultrasonography Images for Differentiating Malignant from Benign American College of Radiology Thyroid Imaging, Reporting and Data System (TI-RADS) 3-5 Thyroid Nodules.
Pang L; Yang X; Zhang P; Ding L; Yuan J; Liu H; Liu J; Gong X; Yu M; Luo W
Ultrasound Med Biol; 2024 Apr; 50(4):557-563. PubMed ID: 38262884
[TBL] [Abstract][Full Text] [Related]
4. Benefits of Contrast-Enhanced Ultrasonography to the Differential Diagnosis of TI-RADS 4-5 Thyroid Nodules.
Yu P; Niu S; Gao S; Tian H; Zhu J
Appl Bionics Biomech; 2022; 2022():7386516. PubMed ID: 35465180
[TBL] [Abstract][Full Text] [Related]
5. The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma.
Zhu J; Li X; Wei X; Yang X; Zhao J; Zhang S; Guo Z
Cancer Med; 2019 Jul; 8(7):3389-3400. PubMed ID: 31070290
[TBL] [Abstract][Full Text] [Related]
6. Malignancy risk stratification of thyroid nodules: comparisons of four ultrasound Thyroid Imaging Reporting and Data Systems in surgically resected nodules.
Wang Y; Lei KR; He YP; Li XL; Ren WW; Zhao CK; Bo XW; Wang D; Sun CY; Xu HX
Sci Rep; 2017 Sep; 7(1):11560. PubMed ID: 28912438
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma: A systematic review and meta-analysis.
Ding Y; Peng Y; Zhang J; Pan X; Huang X; Zhang CQ
Medicine (Baltimore); 2024 Apr; 103(15):e37768. PubMed ID: 38608080
[TBL] [Abstract][Full Text] [Related]
8. The ultrasound-based radiomics-clinical machine learning model to predict papillary thyroid microcarcinoma in TI-RADS 3 nodules.
Chen Z; Zhan W; Wu Z; He H; Wang S; Huang X; Xu Z; Yang Y
Transl Cancer Res; 2024 Jan; 13(1):278-289. PubMed ID: 38410213
[TBL] [Abstract][Full Text] [Related]
9. Value of CEUS features in diagnosing thyroid nodules with halo sign on B-mode ultrasound.
Chen XJ; Huang LJ; Mao F; Yuan HX; Wang X; Lu Q; Dong CH
BMC Med Imaging; 2023 Jan; 23(1):11. PubMed ID: 36681788
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules.
Fan J; Tao L; Zhan W; Li W; Kuang L; Zhao Y; Zhou W
Front Endocrinol (Lausanne); 2023; 14():1240615. PubMed ID: 38250738
[TBL] [Abstract][Full Text] [Related]
11. Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma.
Liu Y; Liu H; Qian CL; Lin MS; Li FH
Sci Rep; 2017 May; 7(1):1472. PubMed ID: 28469180
[TBL] [Abstract][Full Text] [Related]
12. The Utility of Contrast-Enhanced Ultrasound (CEUS) in Assessing the Risk of Malignancy in Thyroid Nodules.
Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Bakuła-Zalewska E; Góralski P; Gałczyński J; Dedecjus M
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791990
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of high frame frequency contrast-enhanced ultrasound in renal tumors.
Zhang W; Wang J; Chen L
BMC Med Imaging; 2024 Mar; 24(1):71. PubMed ID: 38528467
[TBL] [Abstract][Full Text] [Related]
14. Contrast Enhancement Ultrasound Improves Diagnostic Accuracy for Thyroid Nodules: A Prospective Multicenter Study.
Li J; Dou J; Li H; Xiao F; Yu J; Xie M; Zhou P; Liang L; Zhou G; Che Y; Liu C; Cong Z; Liu F; Han Z; Liang P
J Endocr Soc; 2023 Dec; 8(1):bvad145. PubMed ID: 38075563
[TBL] [Abstract][Full Text] [Related]
15. US Risk Stratification System for Follicular Thyroid Neoplasms.
Li J; Li C; Zhou X; Huang J; Yang P; Cang Y; Zhai H; Huang R; Mu Y; Gou X; Zhang Y; Yu J; Liang P
Radiology; 2023 Nov; 309(2):e230949. PubMed ID: 37987664
[TBL] [Abstract][Full Text] [Related]
16. Value of high frame rate contrast enhanced ultrasound in gallbladder wall thickening in non-acute setting.
Zhu L; Li N; Zhu Y; Han P; Jiang B; Li M; Luo Y; Clevert DA; Fei X
Cancer Imaging; 2024 Jan; 24(1):7. PubMed ID: 38191513
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors and Prediction Models for Postoperative Pathologically Malignant TI-RADS 3 Thyroid Nodules.
Peng B; Zhang S; Du F
Ear Nose Throat J; 2024 Feb; ():1455613241228078. PubMed ID: 38380607
[No Abstract] [Full Text] [Related]
18. Performance of Contrast-Enhanced Ultrasound in Thyroid Nodules: Review of Current State and Future Perspectives.
Radzina M; Ratniece M; Putrins DS; Saule L; Cantisani V
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771632
[TBL] [Abstract][Full Text] [Related]
19. Contrast-Enhanced Ultrasonography for Transabdominal and Transrectal Ultrasound in Staging Cervical Cancer: A Reliability Study.
Zhang J; Xiang JD; Jia C; Du LF; Li F
Ultrasound Med Biol; 2023 Oct; 49(10):2283-2290. PubMed ID: 37495499
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of contrast-enhanced ultrasound in breast lesions: what diagnostic models could be used for lesions of different sizes?
Fu N; Li J; Wang B; Jiang Y; Li S; Niu R; Wang Z
Gland Surg; 2023 Dec; 12(12):1654-1667. PubMed ID: 38229844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
